Irbesartan

Chemical formula: C₂₅H₂₈N₆O  Molecular mass: 428.529 g/mol  PubChem compound: 3749

Therapeutic indications

Irbesartan is indicated for:

Essential hypertension

Population group: only adults (18 years old or older)

Essential hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Renal disease with hypertension and type 2 diabetes mellitus

Population group: only adults (18 years old or older)

Irbesartan is indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Irbesartan is contraindicated in the following cases:

Pregnancy

Pregnancy

Aliskiren in diabetes mellitus or renal impairment

Aliskiren and additionally at least one of
Diabetes mellitus



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2021: AVAPRO Film-coated tablet
Summary of Product Characteristics (SPC) 2023: APROVEL Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈